Transbronchial lung cryobiopsy: prospective safety evaluation and 90-day mortality after a standardized examination protocol.
Journal Information
Full Title: Ther Adv Respir Dis
Abbreviation: Ther Adv Respir Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pulmonary Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."
"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors acknowledge support from Open Access Publishing Fund of Karl Landsteiner University of Health Sciences, Krems, Austria."
"Conclusion:: As it gradually becomes the invasive procedure of choice in unclear DPLD, TBLC is a safe procedure with a low 30- and 90-day mortality.: Trial registration ID: DRKS00026746 (German Clinical Trial Register)"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025